Metabolic syndrome and nuclear receptors

The book provides detailed up-to-date information on Metabolic or Reaven's syndrome and the nuclear perixisome proliferator-activated receptor (PPAR) discovered in the mid-1990s. PPARs are now considered to be one of the links in lipid and glucose metabolism and in the processes of inflammation and tumorigenesis. The book summarizes the importance of PPAR receptors in clinical medicine not only in their relationship to obesity, insulin resistance and diabetes, but also in the possible mechanism by which these diseases are linked to other complications such as malignant tumors, cardiovascular and other diseases. PPAR stimulators are already used in the treatment of hyperlipidemia (fibrates) or type 2 diabetes (glitazones). The text is highly beneficial for internists, diabetologists, endocrinologists, respectively. for all medical disciplines whose development is influenced by the rapid increase of civilisation diseases.